Soft Tissue Allografts: Global Markets
Report Scope
The report will provide details about the soft tissue allografts used in the treatment of dental disease, facial dental surgery, orthopedic surgery, and other surgical processes. It will also highlight the current and future market potentiality of soft tissue allografts with detailed analysis of the competitive environment. Drivers, restraints, opportunities, pricing analysis, prevalence or incidence dental diseases, orthopedic surgeries using allografts, and the regulatory scenario assessment will be covered in the report. The report includes a market projection for 2026, and a market share analysis for key players.
This report segments the market for soft tissue allografts based on products, applications, and geography. Product types are cartilage allografts, tendon allografts, meniscus allografts, dental allografts, collagen allografts, and amniotic allografts. Applications are orthopedic, dentistry, wound care, and others.
By geographical region, the market is segmented into North America, Europe, Asia-Pacific, Latin America, and the Middle East & Africa. Detailed analysis of major countries such as the U.S., Germany, the U.K., Italy, France, Spain, Japan, China, India, Brazil, Mexico, GCC countries, and South Africa will be covered in the regional segment. For market estimates, data will be provided for 2020 as the base year, with estimates for 2021 and forecast value for 2026.
Tooth loss is very common and can happen as a result of disease or trauma, and the use of dental implants to provide support for the replacement of missing teeth has a long and multifaceted history. Statistics by the American Association of Oral and Maxillofacial Surgeons show that 69% of adults ages 35 to 44 have lost at least one permanent tooth to an accident, gum disease, a failed root canal, or tooth decay. Furthermore, by age 74, 26% of adults have lost all of their permanent teeth. Research on dental implant designs, materials and techniques has increased in the past few years and is expected to expand in the future due to the recent growth of the market for dental implants and the rise in demand for cosmetic dentistry, which points to increased demand for soft tissue allografts.
The increase in life expectancy and oral hygiene concerns have increased total dental visits; and additionally, the aging population plays a pivotal role in driving the demand for soft tissue allografts.
The report also includes a discussion of the major drivers and global dynamics, along with the political, economic, social, and technological factors that will have an impact on the market. Market estimates and forecast figures are provided for all major market segments. A discussion of the major players is included in the competitive landscape section, which provides trends in product launches, collaborations, mergers and acquisitions, and other agreements.
Report Includes:
The report will provide details about the soft tissue allografts used in the treatment of dental disease, facial dental surgery, orthopedic surgery, and other surgical processes. It will also highlight the current and future market potentiality of soft tissue allografts with detailed analysis of the competitive environment. Drivers, restraints, opportunities, pricing analysis, prevalence or incidence dental diseases, orthopedic surgeries using allografts, and the regulatory scenario assessment will be covered in the report. The report includes a market projection for 2026, and a market share analysis for key players.
This report segments the market for soft tissue allografts based on products, applications, and geography. Product types are cartilage allografts, tendon allografts, meniscus allografts, dental allografts, collagen allografts, and amniotic allografts. Applications are orthopedic, dentistry, wound care, and others.
By geographical region, the market is segmented into North America, Europe, Asia-Pacific, Latin America, and the Middle East & Africa. Detailed analysis of major countries such as the U.S., Germany, the U.K., Italy, France, Spain, Japan, China, India, Brazil, Mexico, GCC countries, and South Africa will be covered in the regional segment. For market estimates, data will be provided for 2020 as the base year, with estimates for 2021 and forecast value for 2026.
Tooth loss is very common and can happen as a result of disease or trauma, and the use of dental implants to provide support for the replacement of missing teeth has a long and multifaceted history. Statistics by the American Association of Oral and Maxillofacial Surgeons show that 69% of adults ages 35 to 44 have lost at least one permanent tooth to an accident, gum disease, a failed root canal, or tooth decay. Furthermore, by age 74, 26% of adults have lost all of their permanent teeth. Research on dental implant designs, materials and techniques has increased in the past few years and is expected to expand in the future due to the recent growth of the market for dental implants and the rise in demand for cosmetic dentistry, which points to increased demand for soft tissue allografts.
The increase in life expectancy and oral hygiene concerns have increased total dental visits; and additionally, the aging population plays a pivotal role in driving the demand for soft tissue allografts.
The report also includes a discussion of the major drivers and global dynamics, along with the political, economic, social, and technological factors that will have an impact on the market. Market estimates and forecast figures are provided for all major market segments. A discussion of the major players is included in the competitive landscape section, which provides trends in product launches, collaborations, mergers and acquisitions, and other agreements.
Report Includes:
- 31 data tables and 22 additional tables
- An updated review and in-depth analysis of the global market for soft tissue allografts
- Analyses of the global market trends, with data from 2019-2020, estimates for 2021, and projections of compound annual growth rates (CAGRs) through 2026
- Estimation of current market size and revenue forecast for global soft tissue allografts market, and corresponding market share analysis by product type, application and geography
- Highlights of current and future market potential for soft tissue allografts with clinical applications in the treatment of dental disease, facial dental surgery, orthopedic surgery, and other surgical process
- Discussion of market dynamics, industry structure, pricing analysis, prevalence or incidence dental diseases, regulatory scenario, and penetration of technologies within the biotech industry
- Coverage of country specific data and analysis for the U.S., Canada, Mexico, Germany, UK, France, Italy, Spain, Brazil, Argentina, China, Japan, India, Australia, GCC countries and South Africa within the regional segment
- Impact analysis of COVID-19 pandemic on the growth of this market
- Review of patents issued for tissue allograft products and therapies, new developments and potential markets for future developments
- Discussion of market regulations and reimbursement policies for transplant procedures within/outside the U.S., and treatment in the EU countries
- Insight into the growth development strategies of the major players operating within the global market and their key competitive landscape
- Profile descriptions of the leading industry players, including Anika Therapeutics Inc., Cook Medical Inc., Johnson & Johnson, Straumann Holding AG, and Zimmer Biomet Holdings
CHAPTER 1 INTRODUCTION
Study Goals and Objectives
Reasons for Doing This Study
Scope of Report
Information Sources
Methodology
Geographic Breakdown
Analyst's Credentials
BCC Custom Research
Related BCC Research Reports
CHAPTER 2 SUMMARY AND HIGHLIGHTS
CHAPTER 3 MARKET AND TECHNOLOGY BACKGROUND
Soft Tissue Allografts
General Overview of Joint Pain and Related Disorders
Osteoarthritis
Rheumatoid Arthritis
Wound Care
Organ Transplantation Alternatives
Trends in Soft Tissue Allografts Techniques and Their Alternatives
3D Tissue Assembly
Nanotechnology for Tissue Regeneration
Innovation by Small Firms
CHAPTER 4 MARKET DYNAMICS
Market Drivers
Increase in the Incidence of Chronic Diseases
Rise in the Geriatric Population
Rising Awareness of Importance of Soft Tissues in Sport Injuries
New Therapeutic Pathways for Organ Transplantation and Their Alternatives
Market Restraints
Challenges in Government Approval Process for Orthopedic Devices
Soft Tissue Graft Lower Outcome Challenges
Market Opportunities
Growing Economic Benefits of Organ and Tissue Transplants
Increasing Demand for Cosmetic Dentistry
CHAPTER 5 MARKET BREAKDOWN BY PRODUCT
Orthopedic Alternatives
Global Market for Soft Tissue Allografts
Cartilage Allografts
Market Size and Forecast
Tendon Allografts
Market Size and Forecast
Meniscus Allografts
Market Size and Forecast
Dental Allografts
Market Size and Forecast
Collagen Allografts
Market Size and Forecast
Market Size and Forecast
Amniotic Allografts
CHAPTER 6 MARKET BREAKDOWN BY APPLICATION
Global Market for Soft Tissue Allografts
Orthopedic Applications
Market Size and Forecast
Dentistry
Market Size and Forecast
Wound Care
Market Size and Forecast
Other Applications
Market Size and Forecast
CHAPTER 7 MARKET BREAKDOWN BY REGION
Global Market for Soft Tissue Allografts by Region
North America
United States
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Spain
Rest of Europe
Asia-Pacific
Japan
China
India
Australia and New Zealand
Rest of Asia-Pacific
Latin America
Market Analysis
Brazil
Argentina
Rest of Latin American Countries
Middle East & Africa
Market Analysis
GCC Countries
South Africa
Rest of Middle Eastern & African Countries
CHAPTER 8 IMPACT OF COVID-19
Introduction
Impact on Wound Care and Telehealth Management Program
Impact on Kidney Transplant Program
Donor Testing
COVID-19 in Transplant Recipients
Minimizing Infection Risk in Recipients
Future Perspectives
CHAPTER 9 REGULATIONS AND REIMBURSEMENT
Regulations in the U.S.
U.S. Federal Regulation of Human Tissue
History of Regulation in the U.S.
Regulations Outside the U.S.
Reimbursement in the U.S.
Organ Acquisition Costs
Reimbursement for Hospital Costs
Reimbursement for Physician Services
Reimbursement Outside the U.S.
Treatment in EU Countries
CHAPTER 10 COMPETITIVE LANDSCAPE
Market Share Analysis of Major Players
Mergers and Acquisitions
Key Developments
Mergers and Acquisitions in 2016-2018
CHAPTER 11 COMPANY PROFILES
ALLOSOURCE INC.
ANIKA THERAPEUTICS INC.
ARTHREX INC.
BIOHORIZONS IPH
BIOTISSUE TECHNOLOGIES GMBH
COOK MEDICAL INC.
GLOBUS MEDICAL INC.
INTEGRA LIFESCIENCES CORP.
JOHNSON & JOHNSON
MIMEDX GROUP INC.
ORGANOGENESIS INC.
SEASPINE
STRAUMANN HOLDING AG.
ZIMMER BIOMET HOLDINGS
CHAPTER 12 APPENDIX: ACRONYMS
Study Goals and Objectives
Reasons for Doing This Study
Scope of Report
Information Sources
Methodology
Geographic Breakdown
Analyst's Credentials
BCC Custom Research
Related BCC Research Reports
CHAPTER 2 SUMMARY AND HIGHLIGHTS
CHAPTER 3 MARKET AND TECHNOLOGY BACKGROUND
Soft Tissue Allografts
General Overview of Joint Pain and Related Disorders
Osteoarthritis
Rheumatoid Arthritis
Wound Care
Organ Transplantation Alternatives
Trends in Soft Tissue Allografts Techniques and Their Alternatives
3D Tissue Assembly
Nanotechnology for Tissue Regeneration
Innovation by Small Firms
CHAPTER 4 MARKET DYNAMICS
Market Drivers
Increase in the Incidence of Chronic Diseases
Rise in the Geriatric Population
Rising Awareness of Importance of Soft Tissues in Sport Injuries
New Therapeutic Pathways for Organ Transplantation and Their Alternatives
Market Restraints
Challenges in Government Approval Process for Orthopedic Devices
Soft Tissue Graft Lower Outcome Challenges
Market Opportunities
Growing Economic Benefits of Organ and Tissue Transplants
Increasing Demand for Cosmetic Dentistry
CHAPTER 5 MARKET BREAKDOWN BY PRODUCT
Orthopedic Alternatives
Global Market for Soft Tissue Allografts
Cartilage Allografts
Market Size and Forecast
Tendon Allografts
Market Size and Forecast
Meniscus Allografts
Market Size and Forecast
Dental Allografts
Market Size and Forecast
Collagen Allografts
Market Size and Forecast
Market Size and Forecast
Amniotic Allografts
CHAPTER 6 MARKET BREAKDOWN BY APPLICATION
Global Market for Soft Tissue Allografts
Orthopedic Applications
Market Size and Forecast
Dentistry
Market Size and Forecast
Wound Care
Market Size and Forecast
Other Applications
Market Size and Forecast
CHAPTER 7 MARKET BREAKDOWN BY REGION
Global Market for Soft Tissue Allografts by Region
North America
United States
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Spain
Rest of Europe
Asia-Pacific
Japan
China
India
Australia and New Zealand
Rest of Asia-Pacific
Latin America
Market Analysis
Brazil
Argentina
Rest of Latin American Countries
Middle East & Africa
Market Analysis
GCC Countries
South Africa
Rest of Middle Eastern & African Countries
CHAPTER 8 IMPACT OF COVID-19
Introduction
Impact on Wound Care and Telehealth Management Program
Impact on Kidney Transplant Program
Donor Testing
COVID-19 in Transplant Recipients
Minimizing Infection Risk in Recipients
Future Perspectives
CHAPTER 9 REGULATIONS AND REIMBURSEMENT
Regulations in the U.S.
U.S. Federal Regulation of Human Tissue
History of Regulation in the U.S.
Regulations Outside the U.S.
Reimbursement in the U.S.
Organ Acquisition Costs
Reimbursement for Hospital Costs
Reimbursement for Physician Services
Reimbursement Outside the U.S.
Treatment in EU Countries
CHAPTER 10 COMPETITIVE LANDSCAPE
Market Share Analysis of Major Players
Mergers and Acquisitions
Key Developments
Mergers and Acquisitions in 2016-2018
CHAPTER 11 COMPANY PROFILES
ALLOSOURCE INC.
ANIKA THERAPEUTICS INC.
ARTHREX INC.
BIOHORIZONS IPH
BIOTISSUE TECHNOLOGIES GMBH
COOK MEDICAL INC.
GLOBUS MEDICAL INC.
INTEGRA LIFESCIENCES CORP.
JOHNSON & JOHNSON
MIMEDX GROUP INC.
ORGANOGENESIS INC.
SEASPINE
STRAUMANN HOLDING AG.
ZIMMER BIOMET HOLDINGS
CHAPTER 12 APPENDIX: ACRONYMS
LIST OF TABLES
Summary Table: Global Market for Soft Tissue Allografts, by Product, Through 2026
Table 1: Cost of Hard-To-Heal Wounds
Table 2: MiMedx: Patent Portfolio
Table 3: Selected Global Commercial Opportunities for New Orthopedic Devices in the Future
Table 4: Indications for Bioartificial Liver Transplantation
Table 5: Global Market for Soft Tissue Allografts, by Product, Through 2026
Table 6: Cartilage and Soft Tissue Biologics and Biomaterials
Table 7: Global Market for Cartilage Allografts, by Region, Through 2026
Table 8: Global Market for Tendon Allografts, by Region, Through 2026
Table 9: Global Market for Meniscus Allografts, by Region, Through 2026
Table 10: Global Market for Dental Allografts, by Region, Through 2026
Table 11: Global Market for Collagen Allografts, by Region, Through 2026
Table 12: Global Market for Amniotic Allografts, by Region, Through 2026
Table 13: Global Market for Soft Tissue Allografts, by Application, Through 2026
Table 14: Global Market for Orthopedic Applications in Soft Tissue Allografts, by Region, Through 2026
Table 15: Global Market for Dentistry Applications in Soft Tissue Allografts, by Region, Through 2026
Table 16: Global Market for Wound Care Applications in Soft Tissue Allografts, by Region, Through 2026
Table 17: Global Market for Other Applications in the Soft Tissue Allografts, by Region, Through 2026
Table 18: Global Market for Soft Tissue Allografts, by Region, Through 2026
Table 19: North American Market for Soft Tissue Allografts, by Product, Through 2026
Table 20: North American Market for Soft Tissue Allografts, by Application, Through 2026
Table 21: North American Market for Soft Tissue Allografts, by Country, Through 2026
Table 22: European Market for Soft Tissue Allografts, by Product, Through 2026
Table 23: European Market for Soft Tissue Allografts, by Application, Through 2026
Table 24: European Market for Soft Tissue Allografts, by Country, Through 2026
Table 25: Examples of the Cost of Bone Damage Repair and Related Disorders in Europe
Table 26: Asia-Pacific Market for Soft Tissue Allografts, by Product, Through 2026
Table 27: Asia-Pacific Market for Soft Tissue Allografts, by Application, Through 2026
Table 28: Asia-Pacific Market for Soft Tissue Allografts, by Country, Through 2026
Table 29: Joint Replacement Procedures in Australia, 2017
Table 30: Latin American Market for Soft Tissue Allografts, by Product, Through 2026
Table 31: Latin American Market for Soft Tissue Allografts, by Application, Through 2026
Table 32: Latin American Market for Soft Tissue Allografts, by Country, Through 2026
Table 33: Middle Eastern & African Market for Soft Tissue Allografts, by Product, Through 2026
Table 34: Middle Eastern & African Market for Soft Tissue Allografts, by Application, Through 2026
Table 35: Registered Liver Transplantations (LT)/Kidney Transplantation in Middle East Countries, 2017
Table 36: Middle Eastern & African Market for Soft Tissue Allografts, by Country, Through 2026
Table 37: Number of Organ Transplant Procedures in Turkey, by Type of Organ, 2019-2020
Table 38: Selected Transplant Industry Acquisitions, 2010-2020
Table 39: AlloSource Inc.: Product Portfolio
Table 40: Anika Therapeutics Inc.: Product Portfolio
Table 41: BioHorizons: Products
Table 42: Cook Medical Inc.: Product Portfolio
Table 43: Globus Medical Inc.: Product Portfolio
Table 44: Integra: Product Portfolio
Table 45: Johnson & Johnson: Product Portfolio
Table 46: MiMedx Group Inc.: Product Portfolio
Table 47: Organogenesis Inc.: Product Portfolio
Table 48: SeaSpine: Product Portfolio
Table 49: Straumann Holding AG: Product Portfolio
Table 50: Zimmer Biomet Holdings: Product Portfolio
Table 51: Zimmer Biomet Holdings: Products
Table 52: Acronyms Used in This Report
Summary Table: Global Market for Soft Tissue Allografts, by Product, Through 2026
Table 1: Cost of Hard-To-Heal Wounds
Table 2: MiMedx: Patent Portfolio
Table 3: Selected Global Commercial Opportunities for New Orthopedic Devices in the Future
Table 4: Indications for Bioartificial Liver Transplantation
Table 5: Global Market for Soft Tissue Allografts, by Product, Through 2026
Table 6: Cartilage and Soft Tissue Biologics and Biomaterials
Table 7: Global Market for Cartilage Allografts, by Region, Through 2026
Table 8: Global Market for Tendon Allografts, by Region, Through 2026
Table 9: Global Market for Meniscus Allografts, by Region, Through 2026
Table 10: Global Market for Dental Allografts, by Region, Through 2026
Table 11: Global Market for Collagen Allografts, by Region, Through 2026
Table 12: Global Market for Amniotic Allografts, by Region, Through 2026
Table 13: Global Market for Soft Tissue Allografts, by Application, Through 2026
Table 14: Global Market for Orthopedic Applications in Soft Tissue Allografts, by Region, Through 2026
Table 15: Global Market for Dentistry Applications in Soft Tissue Allografts, by Region, Through 2026
Table 16: Global Market for Wound Care Applications in Soft Tissue Allografts, by Region, Through 2026
Table 17: Global Market for Other Applications in the Soft Tissue Allografts, by Region, Through 2026
Table 18: Global Market for Soft Tissue Allografts, by Region, Through 2026
Table 19: North American Market for Soft Tissue Allografts, by Product, Through 2026
Table 20: North American Market for Soft Tissue Allografts, by Application, Through 2026
Table 21: North American Market for Soft Tissue Allografts, by Country, Through 2026
Table 22: European Market for Soft Tissue Allografts, by Product, Through 2026
Table 23: European Market for Soft Tissue Allografts, by Application, Through 2026
Table 24: European Market for Soft Tissue Allografts, by Country, Through 2026
Table 25: Examples of the Cost of Bone Damage Repair and Related Disorders in Europe
Table 26: Asia-Pacific Market for Soft Tissue Allografts, by Product, Through 2026
Table 27: Asia-Pacific Market for Soft Tissue Allografts, by Application, Through 2026
Table 28: Asia-Pacific Market for Soft Tissue Allografts, by Country, Through 2026
Table 29: Joint Replacement Procedures in Australia, 2017
Table 30: Latin American Market for Soft Tissue Allografts, by Product, Through 2026
Table 31: Latin American Market for Soft Tissue Allografts, by Application, Through 2026
Table 32: Latin American Market for Soft Tissue Allografts, by Country, Through 2026
Table 33: Middle Eastern & African Market for Soft Tissue Allografts, by Product, Through 2026
Table 34: Middle Eastern & African Market for Soft Tissue Allografts, by Application, Through 2026
Table 35: Registered Liver Transplantations (LT)/Kidney Transplantation in Middle East Countries, 2017
Table 36: Middle Eastern & African Market for Soft Tissue Allografts, by Country, Through 2026
Table 37: Number of Organ Transplant Procedures in Turkey, by Type of Organ, 2019-2020
Table 38: Selected Transplant Industry Acquisitions, 2010-2020
Table 39: AlloSource Inc.: Product Portfolio
Table 40: Anika Therapeutics Inc.: Product Portfolio
Table 41: BioHorizons: Products
Table 42: Cook Medical Inc.: Product Portfolio
Table 43: Globus Medical Inc.: Product Portfolio
Table 44: Integra: Product Portfolio
Table 45: Johnson & Johnson: Product Portfolio
Table 46: MiMedx Group Inc.: Product Portfolio
Table 47: Organogenesis Inc.: Product Portfolio
Table 48: SeaSpine: Product Portfolio
Table 49: Straumann Holding AG: Product Portfolio
Table 50: Zimmer Biomet Holdings: Product Portfolio
Table 51: Zimmer Biomet Holdings: Products
Table 52: Acronyms Used in This Report
LIST OF FIGURES
Summary Figure: Global Market Shares of Soft Tissue Allografts, by Product, 2020
Figure 1: Nanotechnology and Tissue Regeneration
Figure 2: Number of Elderly (? 65 Years) Receiving Kidney Transplantation in the U.S., 2014-2018
Figure 3: Number of Diabetes Patients Globally (20 to 79 Years of Age), 2000-2045
Figure 4: Percentage Distribution of Population Aged 65 and Above, by Region, 2015 and 2050
Figure 5: Number of Kidney Transplants, by Country, 2015
Figure 6: Patients on Waiting List vs. Transplants Performed in the U.S., by Organ, 2019
Figure 7: Global Market Shares of Soft Tissue Allografts, by Product, 2020
Figure 8: Global Market for Cartilage Allografts, 2019-2026
Figure 9: Global Market for Cartilage Allografts, by Region, 2019-2026
Figure 10: Global Market for Tendon Allografts, 2019-2026
Figure 11: Global Market for Tendon Allografts, by Region, 2019-2026
Figure 12: Global Market for Meniscus Allografts, 2019-2026
Figure 13: Global Market for Meniscus Allografts, by Region, 2019-2026
Figure 14: Global Market for Dental Allografts, 2019-2026
Figure 15: Number of People Affected, by Common Dental Diseases, 2010
Figure 16: Global Market for Dental Allografts, by Region, 2019-2026
Figure 17: Global Market for Collagen Allografts, 2019-2026
Figure 18: Global Market for Collagen Allografts, by Region, 2019-2026
Figure 19: Percentages of Type III Collagen Found in Mammalian Dermis
Figure 20: Global Market for Amniotic Allografts, 2019-2026
Figure 21: Global Market for Amniotic Allografts, by Region, 2019-2026
Figure 22: Global Market Shares of Soft Tissue Allografts, by Application, 2020
Figure 23: Global Market for Orthopedic Applications in Soft Tissue Allografts, 2019-2026
Figure 24: Global Market for Orthopedic Applications in Soft Tissue Allografts, by Region, 2019-2026
Figure 25: Global Market for Dentistry Applications in Soft Tissue Allografts, 2019-2026
Figure 26: Global Market for Dentistry Applications in Soft Tissue Allografts, by Region, 2019-2026
Figure 27: Global Market for Wound Care Applications in Soft Tissue Allografts, 2019-2026
Figure 28: Global Market for Wound Care Applications in Soft Tissue Allografts, by Region, 2019-2026
Figure 29: Global Market for Other Applications in Soft Tissue Allografts, 2019-2026
Figure 30: Global Market for Other Applications in Soft Tissue Allografts, by Region, 2019-2026
Figure 31: Global Market Shares of Soft Tissue Allografts, by Region, 2020
Figure 32: North American Market Shares of Soft Tissue Allografts, by Product, 2020
Figure 33: North American Market Shares of Soft Tissue Allografts, by Application, 2020
Figure 34: North American Market Shares for Soft Tissue Allografts, by Country, 2020
Figure 35: United States’ Market for Soft Tissue Allografts, 2019-2026
Figure 36: Canadian Market for Soft Tissue Allografts, 2019-2026
Figure 37: Mexican Market for Soft Tissue Allografts, 2019-2026
Figure 38: European Market Shares of Soft Tissue Allografts, by Product, 2020
Figure 39: European Market Shares of Soft Tissue Allografts, by Application, 2020
Figure 40: European Market Shares of Soft Tissue Allografts, by Country, 2020
Figure 41: German Market for Soft Tissue Allografts, 2019-2026
Figure 42: French Market for Soft Tissue Allografts, 2019-2026
Figure 43: U.K. Market for Soft Tissue Allografts, 2019-2026
Figure 44: Italian Market for Soft Tissue Allografts, 2019-2026
Figure 45: Spanish Market for Soft Tissue Allografts, 2019-2026
Figure 46: Rest of Europe’s Market for Soft Tissue Allografts, 2019-2026
Figure 47: Asia-Pacific Market Shares of Soft Tissue Allografts, by Product, 2020
Figure 48: Asia-Pacific Market Shares of Soft Tissue Allografts, by Application, 2020
Figure 49: Asia-Pacific Market Shares for Soft Tissue Allografts, by Country, 2020
Figure 50: Japanese Market for Soft Tissue Allografts, 2019-2026
Figure 51: Chinese Market for Soft Tissue Allografts, 2019-2026
Figure 52: Indian Market for Soft Tissue Allografts, 2019-2026
Figure 53: Australia and New Zealand’s Market for Soft Tissue Allografts, 2019-2026
Figure 54: Rest of Asia-Pacific Market for Soft Tissue Allografts, 2019-2026
Figure 55: Latin American Market Shares for Soft Tissue Allografts, by Product, 2020
Figure 56: Latin American Market Shares for Soft Tissue Allografts, by Application, 2020
Figure 57: Latin American Market Shares for Soft Tissue Allografts and Alternatives, by Country, 2020
Figure 58: Brazilian Market for Soft Tissue Allografts, 2019-2026
Figure 59: Argentinian Market for Soft Tissue Allografts, 2019-2026
Figure 60: Rest of Latin American Countries Market for Soft Tissue Allografts, 2019-2026
Figure 61: Middle Eastern & African Market Shares for Soft Tissue Allografts, by Product, 2020
Figure 62: Middle Eastern & African Market Shares for Soft Tissue Allografts, by Application, 2020
Figure 63: Middle Eastern & African Market Shares for Soft Tissue Allografts, by Country, 2020
Figure 64: GCC Countries Market for Soft Tissue Allografts, 2019-2026
Figure 65: South African Market for Soft Tissue Allografts, 2019-2026
Figure 66: Rest of Middle Eastern & African Countries Market for Soft Tissue Allografts, 2019-2026
Figure 67: Steep Reduction in Organ & Tissue Transplantation Seen During COVID-19
Figure 68: Market Shares of Major Players in the Soft Tissue Allograft, 2020
Figure 69: AlloSource Inc.: Annual Revenue, 2018-2020
Figure 70: Anika Therapeutics Inc.: Annual Revenue, 2016-2020
Figure 71: Anika Therapeutics Inc.: Revenue Shares, by Region/Country, 2020
Figure 72: Anika Therapeutics Inc.: Revenue Shares, by Business Unit, 2020
Figure 73: Johnson & Johnson: Annual Revenue, 2016-2020
Figure 74: Johnson & Johnson: Revenue Shares, by Region/Country, 2019
Figure 75: Johnson & Johnson: Revenue Shares, by Business Unit, 2019
Figure 76: Organogenesis Inc.: Annual Revenue, 2017-2020
Figure 77: Organogenesis Inc.: Revenue Shares by Products, 2020
Figure 78: Straumann Holding AG: Annual Revenue, 2017-2020
Figure 79: Straumann Holding AG: Revenue Shares, by Region/Country, 2020
Figure 80: Zimmer Biomet Holdings: Annual Revenue, 2016-2020
Figure 81: Zimmer Biomet Holdings: Revenue Shares, by Region, 2020
Figure 82: Zimmer Biomet Holdings: Revenue Shares, by Products, 2020
Summary Figure: Global Market Shares of Soft Tissue Allografts, by Product, 2020
Figure 1: Nanotechnology and Tissue Regeneration
Figure 2: Number of Elderly (? 65 Years) Receiving Kidney Transplantation in the U.S., 2014-2018
Figure 3: Number of Diabetes Patients Globally (20 to 79 Years of Age), 2000-2045
Figure 4: Percentage Distribution of Population Aged 65 and Above, by Region, 2015 and 2050
Figure 5: Number of Kidney Transplants, by Country, 2015
Figure 6: Patients on Waiting List vs. Transplants Performed in the U.S., by Organ, 2019
Figure 7: Global Market Shares of Soft Tissue Allografts, by Product, 2020
Figure 8: Global Market for Cartilage Allografts, 2019-2026
Figure 9: Global Market for Cartilage Allografts, by Region, 2019-2026
Figure 10: Global Market for Tendon Allografts, 2019-2026
Figure 11: Global Market for Tendon Allografts, by Region, 2019-2026
Figure 12: Global Market for Meniscus Allografts, 2019-2026
Figure 13: Global Market for Meniscus Allografts, by Region, 2019-2026
Figure 14: Global Market for Dental Allografts, 2019-2026
Figure 15: Number of People Affected, by Common Dental Diseases, 2010
Figure 16: Global Market for Dental Allografts, by Region, 2019-2026
Figure 17: Global Market for Collagen Allografts, 2019-2026
Figure 18: Global Market for Collagen Allografts, by Region, 2019-2026
Figure 19: Percentages of Type III Collagen Found in Mammalian Dermis
Figure 20: Global Market for Amniotic Allografts, 2019-2026
Figure 21: Global Market for Amniotic Allografts, by Region, 2019-2026
Figure 22: Global Market Shares of Soft Tissue Allografts, by Application, 2020
Figure 23: Global Market for Orthopedic Applications in Soft Tissue Allografts, 2019-2026
Figure 24: Global Market for Orthopedic Applications in Soft Tissue Allografts, by Region, 2019-2026
Figure 25: Global Market for Dentistry Applications in Soft Tissue Allografts, 2019-2026
Figure 26: Global Market for Dentistry Applications in Soft Tissue Allografts, by Region, 2019-2026
Figure 27: Global Market for Wound Care Applications in Soft Tissue Allografts, 2019-2026
Figure 28: Global Market for Wound Care Applications in Soft Tissue Allografts, by Region, 2019-2026
Figure 29: Global Market for Other Applications in Soft Tissue Allografts, 2019-2026
Figure 30: Global Market for Other Applications in Soft Tissue Allografts, by Region, 2019-2026
Figure 31: Global Market Shares of Soft Tissue Allografts, by Region, 2020
Figure 32: North American Market Shares of Soft Tissue Allografts, by Product, 2020
Figure 33: North American Market Shares of Soft Tissue Allografts, by Application, 2020
Figure 34: North American Market Shares for Soft Tissue Allografts, by Country, 2020
Figure 35: United States’ Market for Soft Tissue Allografts, 2019-2026
Figure 36: Canadian Market for Soft Tissue Allografts, 2019-2026
Figure 37: Mexican Market for Soft Tissue Allografts, 2019-2026
Figure 38: European Market Shares of Soft Tissue Allografts, by Product, 2020
Figure 39: European Market Shares of Soft Tissue Allografts, by Application, 2020
Figure 40: European Market Shares of Soft Tissue Allografts, by Country, 2020
Figure 41: German Market for Soft Tissue Allografts, 2019-2026
Figure 42: French Market for Soft Tissue Allografts, 2019-2026
Figure 43: U.K. Market for Soft Tissue Allografts, 2019-2026
Figure 44: Italian Market for Soft Tissue Allografts, 2019-2026
Figure 45: Spanish Market for Soft Tissue Allografts, 2019-2026
Figure 46: Rest of Europe’s Market for Soft Tissue Allografts, 2019-2026
Figure 47: Asia-Pacific Market Shares of Soft Tissue Allografts, by Product, 2020
Figure 48: Asia-Pacific Market Shares of Soft Tissue Allografts, by Application, 2020
Figure 49: Asia-Pacific Market Shares for Soft Tissue Allografts, by Country, 2020
Figure 50: Japanese Market for Soft Tissue Allografts, 2019-2026
Figure 51: Chinese Market for Soft Tissue Allografts, 2019-2026
Figure 52: Indian Market for Soft Tissue Allografts, 2019-2026
Figure 53: Australia and New Zealand’s Market for Soft Tissue Allografts, 2019-2026
Figure 54: Rest of Asia-Pacific Market for Soft Tissue Allografts, 2019-2026
Figure 55: Latin American Market Shares for Soft Tissue Allografts, by Product, 2020
Figure 56: Latin American Market Shares for Soft Tissue Allografts, by Application, 2020
Figure 57: Latin American Market Shares for Soft Tissue Allografts and Alternatives, by Country, 2020
Figure 58: Brazilian Market for Soft Tissue Allografts, 2019-2026
Figure 59: Argentinian Market for Soft Tissue Allografts, 2019-2026
Figure 60: Rest of Latin American Countries Market for Soft Tissue Allografts, 2019-2026
Figure 61: Middle Eastern & African Market Shares for Soft Tissue Allografts, by Product, 2020
Figure 62: Middle Eastern & African Market Shares for Soft Tissue Allografts, by Application, 2020
Figure 63: Middle Eastern & African Market Shares for Soft Tissue Allografts, by Country, 2020
Figure 64: GCC Countries Market for Soft Tissue Allografts, 2019-2026
Figure 65: South African Market for Soft Tissue Allografts, 2019-2026
Figure 66: Rest of Middle Eastern & African Countries Market for Soft Tissue Allografts, 2019-2026
Figure 67: Steep Reduction in Organ & Tissue Transplantation Seen During COVID-19
Figure 68: Market Shares of Major Players in the Soft Tissue Allograft, 2020
Figure 69: AlloSource Inc.: Annual Revenue, 2018-2020
Figure 70: Anika Therapeutics Inc.: Annual Revenue, 2016-2020
Figure 71: Anika Therapeutics Inc.: Revenue Shares, by Region/Country, 2020
Figure 72: Anika Therapeutics Inc.: Revenue Shares, by Business Unit, 2020
Figure 73: Johnson & Johnson: Annual Revenue, 2016-2020
Figure 74: Johnson & Johnson: Revenue Shares, by Region/Country, 2019
Figure 75: Johnson & Johnson: Revenue Shares, by Business Unit, 2019
Figure 76: Organogenesis Inc.: Annual Revenue, 2017-2020
Figure 77: Organogenesis Inc.: Revenue Shares by Products, 2020
Figure 78: Straumann Holding AG: Annual Revenue, 2017-2020
Figure 79: Straumann Holding AG: Revenue Shares, by Region/Country, 2020
Figure 80: Zimmer Biomet Holdings: Annual Revenue, 2016-2020
Figure 81: Zimmer Biomet Holdings: Revenue Shares, by Region, 2020
Figure 82: Zimmer Biomet Holdings: Revenue Shares, by Products, 2020
